Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data.
about
Use and misuse of triptans in France: data from the GRIM2000 population survey.Incidence of hospital admission does not equal incidence of disease. Conclusions drawn from data are incorrectTreatment adherence among new triptan users: a 2-year cohort study in TaiwanReference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012Triptans in the Italian population: a drug utilization study and a literature review.History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.Medication overuse headache in Scandinavia.Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse.Treatment of medication-overuse headache: A systematic review.When to stop?Triptans: low utilization and high turnover in the general population.Sumatriptan overdose in episodic cluster headache: a case report of overuse without event.Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats.Reduction of medication costs after detoxification for medication-overuse headache.Intensive community pharmacy intervention had little impact on triptan consumption: a randomized controlled trial.Prevalence of overweight, obesity and physical inactivity in 20- to 29-year-old, Danish men. Relation to sociodemography, physical dysfunction and low socioeconomic status: the Odense Androgen Study.Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ).
P2860
Q30910777-FD1FE1D0-5254-40A8-B4C6-2D4277FCC885Q31696097-CE6E195C-B5A9-4AFD-8776-CF842FFEC321Q34109369-F33CE2C4-0875-427A-958A-2DA2D63222D4Q35697308-BA63F5A5-C06E-4282-8DEE-F34438A34278Q36332554-0DDCA8E8-60E7-4C7C-9B43-E8C91C8389F5Q37155841-377ADCF9-C5A9-4915-8C9F-19593E549766Q37317191-22268784-9229-4092-B5C4-33DEAA2EDA1EQ38476100-791DC4C6-FB33-4556-A341-53A9699CC984Q38540076-4AD6971B-3128-4861-B841-214E2F6F0917Q42993505-512449F4-83DF-4EBE-AB1D-376A0FF64ADDQ43280720-DE56FBB4-2119-445D-89F4-5CCF21CAEC02Q43725569-E5212F1B-489B-4FBA-9916-A48A5E760C3AQ44850907-01B31D74-10BA-4F17-8D21-99C3A5C3FA2CQ46421705-1AF3EFB6-4FB6-4864-8592-2DDA760EE486Q46933055-86838643-057D-46DA-A51C-1A3E5BB63614Q50542934-189169B4-EF0B-4ED1-93FF-FAE079EF7EEBQ52856790-389FEF57-7BE3-4503-8E01-1052ADA13903
P2860
Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Use and overuse of sumatriptan ...... n register and interview data.
@ast
Use and overuse of sumatriptan ...... n register and interview data.
@en
type
label
Use and overuse of sumatriptan ...... n register and interview data.
@ast
Use and overuse of sumatriptan ...... n register and interview data.
@en
prefLabel
Use and overuse of sumatriptan ...... n register and interview data.
@ast
Use and overuse of sumatriptan ...... n register and interview data.
@en
P2860
P1433
P1476
Use and overuse of sumatriptan ...... n register and interview data.
@en
P2860
P304
P356
10.1046/J.1468-2982.1999.019008735.X
P407
P50
P577
1999-10-01T00:00:00Z